Effects of pericardial administration of lidocaineon hemodynamic responses.
心包给药利多卡因对血流动力学反应的影响。
基本信息
- 批准号:14571426
- 负责人:
- 金额:$ 1.34万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2002
- 资助国家:日本
- 起止时间:2002 至 2003
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Background : Tachycardiac responses during anesthesia should be better to avoid in the patients who have ischemic heart disease, especially during off-pump coronary artery bypass grafting surgery that needs the control of heart rate. Decrease of heart rate without change of cardiac contractility is ideal control of heart rate. In order to achieve this purpose, we tried to block the cardiac nerve with injection of local anesthetics given into the pericardial space. Methods : To examine whether a local anesthetic infusion into the pericardial space affects hemodynamics and arrhythmogenicity, we studied anesthetized, mechanical ventilated dogs having pulmonary catheter in place. We perfused the pericardial space with 2.5 or 5ml of 1% lidocaine, 5mi of 2% lidocaine, or normal saline solution for each 10 dogs. In the presence of pericardial lidocaine (1%), we observed the cardiac responses to intravenous atropine or isoproterenol. Further, to examine the inhibitory action to arrhythmia of p … More ericardial lidocaine, an electrical fibrillator was installed to decide the voltage of inducing arrhythmia or ventricular fibrillation. Also six dogs were used for measurement of serum concentration of lidocaine. Results : The pericardial administration of lidocaine soon decreased heart rate (HR) (about 80% from control within 5min, p<0.05), dose-dependently and significantly without changes in stroke volume (SV). In the presence of pericardial lidocaine, HR responses to isoproterenol were significant, but similar to that without pericardial lidocaine. However, HR response to atropine was completely blocked with pericardial lidocaine. Changes of plasma lidocaine concentration were completely different between intravenous injection and pericardial infusion. Intravenous injection of lidocaine elevated plasma concentration of lidocaine immediately, whereas the pericardial infusion of lidocaine elevated it 10min after its administration. The pericardial lidocaine rose the threshold for arrhythmia and ventricular fibrillation (from 1.6V to 2.2V, p<0.01). Conclusions : Pericardial administration of lidocaine well controlled HR, and could preserve HR responses to isoproterenol, but completely blocked HR responses to atropine. And it inhibited arrhythmia and ventricular fibrillation induced by electrical fibrillator. These results suggest that pericardial lidocaine may be suitable for control of HR during off-pump coronary artery bypass grafting surgery. Less
背景:缺血性心脏病患者应避免麻醉过程中出现心动过速反应,特别是在需要控制心率的非体外循环冠状动脉搭桥手术中,理想的控制是降低心率而不改变心肌收缩力。为了达到这一目的,我们尝试通过向心包腔注射局麻药来阻断心脏神经。方法:检查向心包腔内注入局麻药是否会产生影响。为了研究血流动力学和心律失常性,我们研究了装有肺导管的麻醉机械通气狗,每 10 只狗在心包腔内灌注 2.5 或 5 毫升 1% 利多卡因、5 毫升 2% 利多卡因或生理盐水。心包利多卡因(1%),我们观察了静脉注射阿托品或异丙肾上腺素的心脏反应。此外,为了检查心包利多卡因对心律失常的抑制作用,安装了电颤器来确定诱发心律失常或心室颤动的电压,还使用六只狗来测量利多卡因的血清浓度。利多卡因很快就降低了心率 (HR)(5 分钟内比对照降低约 80%,p<0.05),呈剂量依赖性且显着在存在心包利多卡因的情况下,对异丙肾上腺素的 HR 反应显着,但与没有心包利多卡因的 HR 反应相似。然而,心包利多卡因的 HR 反应被完全阻断。静脉注射和心包输注完全不同,静脉注射利多卡因立即升高利多卡因的血浆浓度,而心包输注则明显不同。利多卡因给药 10 分钟后,心包利多卡因升高了心律失常和心室颤动的阈值(从 1.6V 至 2.2V,p<0.01)。但完全阻断了阿托品的 HR 反应,并且抑制了心律失常和心室颤动。这些结果表明,心包利多卡因可能适用于非体外循环冠状动脉搭桥手术期间的心率控制。
项目成果
期刊论文数量(34)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Matsuno H, Kozawa O, Tanabe K, Akamatsu S. et al.: "Lack of α2-antiplasmine promotes pulmonary heart failure via overlease of VEGF after acute myocardial infaretion"Blood. 100・7. 2487-2493 (2002)
Matsuno H、Kozawa O、Tanabe K、Akamatsu S. 等:“急性心肌梗塞后缺乏 α2-抗纤溶酶通过过度释放 VEGF 促进肺心力衰竭”100・7 (2002)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Hirade k et al.: "Thrombin stimulates dissociation and induction of HSP27 via p38 MAPK in vascular smooth muscle cells."Am J Physiol Heart Circ Physiol. 283. H941-H948 (2002)
Hirade k 等人:“凝血酶通过 p38 MAPK 在血管平滑肌细胞中刺激 HSP27 的解离和诱导。”Am J Physiol Heart Circ Physiol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Matsuno H et al.: "Lack of α2-antiplasmin promotes pulmonary heart failure via overrelease of VEGF aftr acute myocardial infarction."Blood. 100. 2487-2493 (2002)
Matsuno H 等人:“急性心肌梗塞后,α2-抗纤溶酶的缺乏会通过 VEGF 的过度释放促进肺心力衰竭。”Blood. 100. 2487-2493 (2002)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Terazawa E et al.: "Changes in calcitonin gene-related peptide, atrial natriuretic peptide and brain natriuretic peptide in patients undergoing coronary artery bypass grafting."Anaesthesia. 58. 223-232 (2003)
Terazawa E 等人:“接受冠状动脉旁路移植术的患者中降钙素基因相关肽、心房钠尿肽和脑钠尿肽的变化。”麻醉。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Akamatsu S et al.: "Automated cardiac output measurement by transesophageal color Doppler echocardiography."Anesth Analg. (in press). (2004)
Akamatsu S 等人:“通过经食管彩色多普勒超声心动图自动测量心输出量。”Anesth Analg。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AKAMATSU Shigeru其他文献
AKAMATSU Shigeru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AKAMATSU Shigeru', 18)}}的其他基金
Investigation on generation and perception of higher-order facial impressions based on the morphable 3D face model and its application to perceptual human interface systems
基于可变形3D人脸模型的高阶面部印象的生成和感知及其在感知人机界面系统中的应用研究
- 批准号:
16K00378 - 财政年份:2016
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of higher-order facial impressions based on the morphable 3D face model and its application to perceptual human interface systems
基于可变形 3D 人脸模型的高阶面部印象生成及其在感知人机界面系统中的应用
- 批准号:
24300087 - 财政年份:2012
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of responses to stress in blood coagulation and fibrinolysis system
凝血纤溶系统应激反应的分子机制
- 批准号:
23592249 - 财政年份:2011
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating factors of the higher-order facial impression caused by the dynamic traits of 3D face and image technologies applied to perceptual human interface systems
研究3D人脸动态特征和应用于感知人机界面系统的图像技术引起的高阶面部印象的因素
- 批准号:
21300084 - 财政年份:2009
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular mechanism of responses to stress in cardiovascular system
心血管系统应激反应的分子机制
- 批准号:
20591825 - 财政年份:2008
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Modeling higher-order visual impression dominant on face and 3D object and its application to impression-driven design scheme in manufacturing
对面部和 3D 物体上占主导地位的高阶视觉印象进行建模及其在制造中印象驱动设计方案中的应用
- 批准号:
18300076 - 财政年份:2006
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Investigation of the role of the fibrinolytic system in cardiac remodeling and its clinical relevance
纤溶系统在心脏重构中的作用及其临床意义的研究
- 批准号:
17591623 - 财政年份:2005
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dynamic Modeling of Higher Order Impression of Faces and its Application to Image Engineering
人脸高阶印象动态建模及其在图像工程中的应用
- 批准号:
15300076 - 财政年份:2003
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Continuous cardiac output measurements using a newly developed pulmonary artery Doppler catheter combined with intravascular ultrasound tehnique.
使用新开发的肺动脉多普勒导管结合血管内超声技术进行连续心输出量测量。
- 批准号:
09557126 - 财政年份:1997
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Right and Left Ventricular Responses to Aortic Unclamping Following Aortic Cross-Clamping. -Effects of Nitric Oxide Inhalation on Cardiac Performance Assessed by Transesophageal Echocardiography
主动脉交叉钳夹后右心室和左心室对主动脉松开的反应。
- 批准号:
08671724 - 财政年份:1996
- 资助金额:
$ 1.34万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
CCND1介导的巨噬细胞功能转变在心梗后心脏功能恢复中的作用及机制研究
- 批准号:82300305
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Myosin19乳酰化致线粒体内嵴结构重排在脓毒症心脏功能障碍中的作用机制
- 批准号:82300561
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ALKBH5介导FoxO3 m6A修饰调控心肌细胞线粒体融合-分裂探究益气温阳法防治脓毒症心脏功能障碍的机制
- 批准号:82305225
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于胎盘糖代谢重编程:探讨增强胎盘P-糖蛋白外排功能降低宫内DEHP暴露致先天性心脏病的调控机制
- 批准号:82300343
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
HADHA乳酸化修饰调控代谢稳态在模拟失重心脏储备功能失调中的作用及机制
- 批准号:32371239
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Activation of sirtuins to prevent adverse cardiac remodeling after CABG
激活sirtuins以预防CABG后不良心脏重塑
- 批准号:
8789384 - 财政年份:2013
- 资助金额:
$ 1.34万 - 项目类别:
Activation of sirtuins to prevent adverse cardiac remodeling after CABG
激活sirtuins以预防CABG后不良心脏重塑
- 批准号:
8620707 - 财政年份:2013
- 资助金额:
$ 1.34万 - 项目类别:
Activation of sirtuins to prevent adverse cardiac remodeling after CABG
激活sirtuins以预防CABG后不良心脏重塑
- 批准号:
8440040 - 财政年份:2013
- 资助金额:
$ 1.34万 - 项目类别:
Inhibition of GRK2 to Prevent Ventricular Remodeling and Heart Failure After CABG
抑制 GRK2 可预防 CABG 后心室重构和心力衰竭
- 批准号:
8750889 - 财政年份:2011
- 资助金额:
$ 1.34万 - 项目类别:
Inhibition of GRK2 to Prevent Ventricular Remodeling and Heart Failure After CABG
抑制 GRK2 可预防 CABG 后心室重构和心力衰竭
- 批准号:
8086228 - 财政年份:2011
- 资助金额:
$ 1.34万 - 项目类别: